{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:16:54Z","timestamp":1788279414632,"version":"build-2803163510"},"reference-count":109,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Basic Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmet.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:09:47Z","timestamp":1784214587000},"page":"1815-1834.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance"],"prefix":"10.1016","volume":"38","author":[{"given":"Qing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baile","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0668-033X","authenticated-orcid":false,"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmet.2026.06.021_bib1","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cmet.2026.06.021_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s42255-023-00812-z","article-title":"Gut hormone co-agonists for the treatment of obesity: from bench to bedside","volume":"5","author":"Nogueiras","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.021_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s42255-019-0095-y","article-title":"Leptin and the endocrine control of energy balance","volume":"1","author":"Friedman","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.cmet.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/cbin.10172","article-title":"Effect of leptin on the gluconeogenesis in calf hepatocytes cultured in vitro","volume":"37","author":"Li","year":"2013","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.cmet.2026.06.021_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249368","article-title":"Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases","volume":"21","author":"Mart\u00ednez-U\u00f1a","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2007-956166","article-title":"Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver","volume":"115","author":"Wein","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cmet.2026.06.021_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","article-title":"Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives","volume":"18","author":"Dalamaga","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cmet.2012.01.002","article-title":"Challenges and opportunities of defining clinical leptin resistance","volume":"15","author":"Myers","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60771","article-title":"CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance","volume":"9","author":"Drori","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.cmet.2026.06.021_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2026.06.021_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37169-6","article-title":"Structural insights into the mechanism of leptin receptor activation","volume":"14","author":"Saxton","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2026.06.021_bib15","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.021_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"\u03b2Klotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.021_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.021_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-pharmtox-032322-093904","article-title":"Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications","volume":"63","author":"Jin","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cmet.2026.06.021_bib20","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41591-023-02427-z","article-title":"The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial","volume":"29","author":"Bhatt","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2026.06.021_bib21","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1210\/clinem\/dgab624","article-title":"LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia","volume":"107","author":"Rader","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cts.12839","article-title":"Evolving Role for Pharmacotherapy in NAFLD\/NASH","volume":"14","author":"Attia","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1530\/EC-20-0152","article-title":"FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation","volume":"9","author":"Keinicke","year":"2020","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.cmet.2026.06.021_bib24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-014-3475-6","article-title":"Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress","volume":"58","author":"Kim","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.cmet.2026.06.021_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103202","article-title":"A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis","volume":"63","author":"Pan","year":"2021","journal-title":"EBiomedicine"},{"key":"10.1016\/j.cmet.2026.06.021_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ijo.2016.238","article-title":"Determination of the half-life of circulating leptin in the mouse","volume":"41","author":"Burnett","year":"2017","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.cmet.2026.06.021_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic Messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s12020-014-0503-8","article-title":"Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice","volume":"49","author":"Ye","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.cmet.2026.06.021_bib29","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib30","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/meta.2000.17695","article-title":"Leptin resistance is associated with hypothalamic leptin receptor mRNA and protein downregulation","volume":"49","author":"Martin","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.cmet.2026.06.021_bib31","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.1038\/oby.2006.319","article-title":"Leptin resistance and obesity","volume":"14","author":"Enriori","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cmet.2026.06.021_bib32","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00391.2020","article-title":"Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet","volume":"320","author":"Park","year":"2021","journal-title":"Am. J. Physiol., Endocrinol. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/379632a0","article-title":"Abnormal splicing of the leptin receptor in diabetic mice","volume":"379","author":"Lee","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.021_bib34","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2026.06.021_bib35","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood","volume":"28","author":"Hsuchou","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.cmet.2026.06.021_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113318","article-title":"Liver Brain Interactions: Focus on FGF21 a Systematic Review","volume":"23","author":"Prida","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094624","article-title":"Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPAR\u03b2\/\u03b4","volume":"22","author":"Mazuecos","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00007.2010","article-title":"Leptin and the central nervous system control of glucose metabolism","volume":"91","author":"Morton","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cmet.2026.06.021_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/2047-783X-15-S2-50","article-title":"Leptin receptors","volume":"15","author":"Gorska","year":"2010","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cmet.2026.06.021_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103233","article-title":"Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver","volume":"24","author":"Su","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.cmet.2026.06.021_bib41","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jmcb\/mjw013","article-title":"The FGF21-adiponectin axis in controlling energy and vascular homeostasis","volume":"8","author":"Hui","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.cmet.2026.06.021_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585346","article-title":"Adiponectin Interacts In-Vitro With Cementoblasts Influencing Cell Migration, Proliferation and Cementogenesis Partly Through the MAPK Signaling Pathway","volume":"11","author":"Yong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cmet.2026.06.021_bib45","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","article-title":"Human pluripotent stem cell-derived organoids as models of liver disease","volume":"159","author":"Ramli","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cmet.2026.06.021_bib46","article-title":"Advancements in MAFLD Modeling with Human Cell and Organoid Models","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib47","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cmet.2026.06.021_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12020-018-1589-1","article-title":"Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy","volume":"60","author":"Brown","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.cmet.2026.06.021_bib49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ando.2024.05.022","article-title":"Leptin replacement therapy in the management of lipodystrophy syndromes","volume":"85","author":"Vigouroux","year":"2024","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.cmet.2026.06.021_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrendo.2016.222","article-title":"The cellular and molecular bases of leptin and ghrelin resistance in obesity","volume":"13","author":"Cui","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cmet.2026.06.021_bib51","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cmet.2019.08.005","article-title":"Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy","volume":"30","author":"Zhao","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib52","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dbi19-0018","article-title":"Leptin: Less Is More","volume":"69","author":"Zhao","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.021_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126420","article-title":"Evidence that peripheral leptin resistance in omental adipose tissue and liver correlates with MASLD in humans","volume":"25","author":"De la Cruz-Color","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1055\/s-2007-981680","article-title":"Obesity reduced the gene expressions of leptin receptors in hypothalamus and liver","volume":"39","author":"Liu","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cmet.2026.06.021_bib55","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jcmgh.2022.07.010","article-title":"Hepatic Leptin Signaling Improves Hyperglycemia by Stimulating MAPK Phosphatase-3 Protein Degradation via STAT3","volume":"14","author":"Huang","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2026.06.021_bib56","article-title":"Metformin induces pyroptosis in leptin receptor-defective hepatocytes via overactivation of the AMPK axis","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cmet.2026.06.021_bib57","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1210\/en.2011-0281","article-title":"Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo","volume":"152","author":"Fisher","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.cmet.2026.06.021_bib58","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.7150\/ijbs.76924","article-title":"Hepatic FGF21: Its Emerging Role in Inter-Organ Crosstalk and Cancers","volume":"18","author":"Sui","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cmet.2026.06.021_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/\u03b2-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib60","article-title":"Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB","volume":"7","author":"Yang","year":"2012","journal-title":"PLOS One"},{"key":"10.1016\/j.cmet.2026.06.021_bib61","doi-asserted-by":"crossref","first-page":"14568","DOI":"10.1073\/pnas.1211611109","article-title":"Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.021_bib62","doi-asserted-by":"crossref","first-page":"32584","DOI":"10.1073\/pnas.1922169117","article-title":"Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.021_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11154-013-9280-6","article-title":"Adiponectin signaling in the liver","volume":"15","author":"Combs","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.cmet.2026.06.021_bib64","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nature08991","article-title":"Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK\/SIRT1","volume":"464","author":"Iwabu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.021_bib65","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.cmet.2026.06.021_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cmet.2026.06.021_bib67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbrc.2018.03.110","article-title":"PPAR\u03b3 alleviated hepatocyte steatosis through reducing SOCS3 by inhibiting JAK2\/STAT3 pathway","volume":"498","author":"Bi","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cmet.2026.06.021_bib68","doi-asserted-by":"crossref","DOI":"10.1186\/s12986-020-0431-y","article-title":"Ascorbate protects liver from metabolic disorder through inhibition of lipogenesis and suppressor of cytokine signaling 3 (SOCS3)","volume":"17","author":"Xu","year":"2020","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.cmet.2026.06.021_bib69","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","article-title":"SOCS1 and SOCS3 in the control of CNS immunity","volume":"30","author":"Baker","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cmet.2026.06.021_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00058","article-title":"SOCS3, a Major Regulator of Infection and Inflammation","volume":"5","author":"Carow","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cmet.2026.06.021_bib71","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/ATVBAHA.110.207464","article-title":"Suppressors of cytokine signaling (SOCS) proteins and JAK\/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3","volume":"31","author":"Tamiya","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cmet.2026.06.021_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.03.047","article-title":"Hydrodynamic delivery of FGF21 gene alleviates obesity and fatty liver in mice fed a high-fat diet","volume":"185","author":"Gao","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cmet.2026.06.021_bib73","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/cvr\/cvab076","article-title":"Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cmet.2026.06.021_bib74","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cmet.2026.06.021_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101564","article-title":"Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity","volume":"64","author":"Claflin","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib76","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ajpath.2021.11.008","article-title":"Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis","volume":"192","author":"Petrescu","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cmet.2026.06.021_bib77","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2012.11.035","article-title":"Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis","volume":"58","author":"Chatterjee","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cmet.2026.06.021_bib78","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.22560","article-title":"Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells","volume":"48","author":"De Minicis","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cmet.2026.06.021_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116780","article-title":"Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis","volume":"10","author":"Pourhoseini","year":"2015","journal-title":"PLOS One"},{"key":"10.1016\/j.cmet.2026.06.021_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady7904","article-title":"Leptin as a key driver for organ fibrogenesis","volume":"11","author":"Sun","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cmet.2026.06.021_bib81","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","article-title":"FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss","volume":"20","author":"Owen","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101324","article-title":"A pyrexic effect of FGF21 independent of energy expenditure and UCP1","volume":"53","author":"Zouhar","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib83","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.021_bib84","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","article-title":"Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice","volume":"131","author":"Lin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cmet.2026.06.021_bib85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib86","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.cmet.2025.05.011","article-title":"FGF21 promotes longevity in diet-induced obesity through metabolic benefits independent of growth suppression","volume":"37","author":"Gliniak","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib87","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.021_bib88","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.cmet.2026.06.021_bib89","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","article-title":"Exercise Alleviates Obesity-Induced Metabolic Dysfunction via Enhancing FGF21 Sensitivity in Adipose Tissues","volume":"26","author":"Geng","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cmet.2026.06.021_bib90","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.gene.2012.07.009","article-title":"Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern","volume":"506","author":"Yan","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.cmet.2026.06.021_bib91","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cmet.2026.06.021_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100028","article-title":"Protocol for Efficient CRISPR\/Cas9\/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells","volume":"1","author":"Tran","year":"2020","journal-title":"Star Protoc."},{"key":"10.1016\/j.cmet.2026.06.021_bib93","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1002\/pmic.200400826","article-title":"Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum","volume":"4","author":"Wang","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.cmet.2026.06.021_bib94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0009-9120(97)00049-0","article-title":"Removal of endotoxin from recombinant protein preparations","volume":"30","author":"Liu","year":"1997","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cmet.2026.06.021_bib95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-024-07701-9","article-title":"Inhibition of IL-11 signalling extends mammalian healthspan and lifespan","volume":"632","author":"Widjaja","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cmet.2026.06.021_bib96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.1806","article-title":"A guide to analysis of mouse energy metabolism","volume":"9","author":"Tsch\u00f6p","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cmet.2026.06.021_bib97","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s42255-025-01360-4","article-title":"A consensus guide to preclinical indirect calorimetry experiments","volume":"7","author":"Banks","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib98","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cmet.2026.06.021_bib99","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcmgh.2022.07.012","article-title":"Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPAR\u03b1\/FGF21 Axis","volume":"14","author":"Qiu","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cmet.2026.06.021_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100086","article-title":"Protocol for Primary Mouse Hepatocyte Isolation","volume":"1","author":"Charni-Natan","year":"2020","journal-title":"Star Protoc."},{"key":"10.1016\/j.cmet.2026.06.021_bib101","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217119120","article-title":"COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis","volume":"120","author":"Barreto","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cmet.2026.06.021_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2879","article-title":"\u03b1-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling","volume":"8","author":"Yuan","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cmet.2026.06.021_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32101-w","article-title":"Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells","volume":"13","author":"Tan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cmet.2026.06.021_bib104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63835","article-title":"Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division","volume":"9","author":"Ow","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.cmet.2026.06.021_bib105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2015.06.004","article-title":"Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation","volume":"22","author":"Hui","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.cmet.2026.06.021_bib106","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cmet.2026.06.021_bib107","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41587-023-01680-4","article-title":"Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis","volume":"41","author":"Hendriks","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cmet.2026.06.021_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123280","article-title":"Optimized 3D Culture of Hepatic Cells for Liver Organoid Metabolic Assays","volume":"10","author":"Gamboa","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cmet.2026.06.021_bib109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["Cell Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413126002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550413126002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:24:33Z","timestamp":1788276273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550413126002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":109,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1550413126002470"],"URL":"https:\/\/doi.org\/10.1016\/j.cmet.2026.06.021","relation":{},"ISSN":["1550-4131"],"issn-type":[{"value":"1550-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance","name":"articletitle","label":"Article Title"},{"value":"Cell Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}